Drugs / Anti-HER2 CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06658951 | Apr 2025 → Apr 2027 expected | — | UTC Therapeutics Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-HER2 CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06658951 ↗ |
| Modality | Cell therapy | “Anti-HER2 CAR-T cell injection” NCT06658951 ↗ |